As such, a comparison is made between the absence of the TP53 mutation and GBM (mentioned as primary GBM in the study) on the one side and the presence of the TP53 mutation and grade 4 astrocytoma (mentioned as secondary GBM in the study) on the other side. This evidence concerns the gene TP53 and astrocytoma (excluding glioblastoma).